By delivering three plasmids simultaneously, encoding Cas9 together with gRNAs targeting Nf1, Trp53 and Pten, we were able to induce highly aggressive tumours, resembling human GBMs in all of the animals (Fig. 1a). The gene discussed is TP53; the disease is neoplasm.